Radiotherapy for Malignant Astrocytomas in the Elderly
Basic Trial Information
|Phase III||Treatment||Completed||70 and over||Other||PHRC, P000502 AOM 98071|
A randomized trial comparing radiotherapy with supportive care in patients aged 70 years or older with newly diagnosed, histologically confirmed anaplastic astrocytoma or glioblastoma, and a Karnofsky performance status > 70.
- Glioblastoma and anaplastic astrocytoma, supratentorial, histologically confirmed
- Brain CT scan or MRI within 28 days before surgery
- Age: 70 years or older
- Karnofsky performance status, 70 or more.
- Life expectancy over 12 weeks
- Informed consent
- Brain radiotherapy
- Severe systemic disease
Trial Contact Information
Trial Lead Organizations/Sponsors
Assistance Publique Hopitaux de Paris
Link to the current ClinicalTrials.gov record.
NLM Identifier NCT00430911
ClinicalTrials.gov processed this data on January 29, 2015
Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.